Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor
Y Chen, J Zheng, L Mo, F Chen, R Li, Y Wang, Q Liang… - Phytomedicine, 2024 - Elsevier
Background Malignant breast cancer cells trigger the over-activation of osteoclast precursor
cells, leading to bone loss and severe pain. Targeted inhibition of osteoclast differentiation …
cells, leading to bone loss and severe pain. Targeted inhibition of osteoclast differentiation …